TORONTO & SARATOGA SPRINGS, N.Y.– Klick Health today announced it has acquired Peregrine Market Access, a leading market access strategy and value communications specialist in life sciences.
The acquisition strengthens Klick Health’s position and ongoing investment in the increasingly important value, access, and reimbursement segments within life sciences commercialization. Peregrine builds on Klick’s proven market access execution capabilities with its industry-leading access strategy, value communications, and payer insights offerings.
“We are thrilled to welcome the entire Peregrine Market Access team to Klick. We commend John Guarino for founding and building such a well-respected and formidable presence in our industry,” said Klick Health Co-Founder and Chairman Leerom Segal. “Peregrine is a remarkable business with a sterling reputation and deep, trusted client relationships, making them the perfect accelerant to our growing market access business. Both Peregrine and Klick are passionate about helping clients get innovative therapies to the patients who need them; we believe this will be a greater challenge for patients in the future, which makes an investment in this area so valuable. Peregrine and Klick both grew up fiercely independent, known for fostering high-performance, entrepreneurial, people-centric cultures. We are excited to bring our organizations together and unleash exponential potential.”
“It has been great getting to know Leerom, the Klick leadership team, and Klick’s depth of expertise in medical, analytics, and AI. Together, we will immediately be able to bring new innovations to clients and redefine what’s possible in market access strategy, analytics, and communications,” said John Guarino, Founder and CEO of Peregrine Market Access. He added, “I’m thrilled to bring our teams together. Our values align incredibly well, and the opportunities from being one team are endless.”
Klick’s Chief Medical Officer Holly Henry added, “Together, we are uniting the best medical and market access teams in North America, and bringing the number of PhD/advanced degree professionals within our medical and access functions alone to around 250 in the Klick Mediverse. We are committed to providing pharmaceutical and biotech clients with an unparalleled level of scientific, medical, and analytics expertise.”
